Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer
However, these medications, classified as GLP-1 receptor agonists (for Semaglutide) and dual GLP-1/GIP receptor agonists (for Tirzepatide), are now being explored for a variety of other potential health benefits beyond their established uses including: improving cardiovascular health, exerting neuroprotective effects, exhibiting anti-inflammatory properties, ad potentially benefitting conditions such as polycystic ovary syndrome (PCOS) and chronic kidney disease
Notably, the FDA's enforcement actions do not extend to legitimate 503A pharmacies operating under state supervision and physician oversight
Any weight loss program is expected to involve some muscle and bone mass loss
In some cases, addressing gut issues (like bacterial or fungal imbalances, digestive issues or inflammation) makes a bigger difference than changing their supplements or removing foods